Revolutionary Technology, Built by Us

At Self.co, we don’t just run tests — we build the technology behind them.

By controlling the entire diagnostic process, from allergen protein development to AI analysis, we make advanced testing more accurate, accessible, and affordable. Our integrated approach means you get a level of precision and trust you won’t find anywhere else.

Leading Publications Highlight the Rise of Allergy-Like Symptoms

Media Partner 1
Media Partner 2
Media Partner 3
Media Partner 4
Media Partner 5
Media Partner 6

Microarray innovation

Using fluorescence-based protein microarray technology on a glass slide — the most sensitive and reliable method available — we can analyze a broad spectrum of allergens and food sensitivities in a single run. Each glass slide contains 21 individual microarrays, allowing multiple samples to be processed simultaneously. This unique design increases efficiency, reduces costs, and ensures exceptional consistency and precision across every result.

Recombinant protein engineering

We produce and purify our own recombinant allergens, ensuring the highest possible quality and reproducibility. By developing these critical building blocks in-house, we maintain full scientific control over test performance.

Smart sampling

COMING SOON

Our porous polymer system, specially designed for our test, enables precise allergy and sensitivity diagnostics from a simple finger prick. Using dry blood microsampling, it ensures stable, accurate results and easy transport, matching the reliability of clinic-based sampling.

Individual calibration curves

Where others use one calibration for all, we apply unique calibration curves for every allergen we test.

This approach enables precise quantification of immune reactions — even at extremely low levels — providing results that go beyond simple “positive/negative” answers.

AI-powered analysis

Every sample is analyzed with AI algorithms that identify patterns, correlations, and cross-reactivities across allergens. But technology is only part of the process: each report is also reviewed by a medical specialist, ensuring that the insights you receive are both data-driven and clinically meaningful.

DualCheck quality system

We verify every result through two independent checks:

Predicted sensitization

Using your questionnaire responses, our system predicts your likely sensitization profile — based on symptoms, triggers, and dietary habits.

Laboratory confirmation

We then compare this prediction against your actual microarray test results to identify any mismatches. If the data and symptoms don’t align, your case is automatically flagged for repeat testing or expert review.

The future of diagnostics

From recombinant allergen protein design to AI-assisted interpretation, we build every layer of our technology to deliver diagnostics that truly understand you — not just your sample.

Self.co team

Supported by innovation grants

Our work has been recognized and supported by leading European innovation programs and health research initiatives. We're proud recipients of grants from:

Innovation Agency Lithuania
ilte
EU Funds
Co-funded by the European Union
Self.co - Understand your allergy - like symptoms